Syneos Health® recognizes that cell and gene therapies present new opportunities for important novel treatments and a unique set of challenges for our sponsor partners, investigators and patients. This is why we have invested in consolidating and expanding our capabilities via our Cell and Gene Therapy (CGT) Consortium. The CGT Consortium is the centerpiece of our knowledge and experience base, focused on bringing the right staff and specific solutions together to deliver your CGT Program.


Download our Fact Sheet



Cell Therapy Trials
Gene Therapy Trials

With deep experience spanning more than a decade, Phases I-IV and over 20 trials in the last 8 years, Syneos Health has delivered cell therapy trials in:

  • Oncology
  • Cardiology
  • Endocrinology
  • Orthopedics
  • Ophthalmology
  • CNS

In the last five years, Syneos Health has conducted over 20 gene therapy trials


  • in 17 countries
  • at over 500 sites
  • spanning Phases I-IV